Search Results - "Kirschner, Janina"
-
1
Antiviral treatment and liver‐related complications in hepatitis delta
Published in Hepatology (Baltimore, Md.) (01-02-2017)“…Hepatitis delta virus (HDV) is the most severe form of viral hepatitis. Pegylated interferon alfa (PEG‐IFNα) is effective in only 25%‐30% of patients and is…”
Get full text
Journal Article -
2
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
Published in Hepatology international (01-12-2023)“…Background and aims Hepatitis D virus (HDV) infection causes the most severe form of chronic viral hepatitis. However, it is still unclear to what extent the…”
Get full text
Journal Article -
3
Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting
Published in PloS one (01-02-2013)“…HCV protease inhibitors (PIs) boceprevir and telaprevir in combination with PEG-Interferon alfa and Ribavirin (P/R) is the new standard of care in the…”
Get full text
Journal Article -
4
Establishment of a Novel Quantitative Hepatitis D Virus (HDV) RNA Assay Using the Cobas TaqMan Platform To Study HDV RNA Kinetics
Published in Journal of Clinical Microbiology (01-06-2010)“…Determination of hepatitis D virus (HDV) viremia represents the "gold standard" for the diagnosis of HDV infection. Hepatitis B virus (HBV)-HDV coinfection…”
Get full text
Journal Article -
5
Influence of different frequencies and insertion depths on the diagnostic accuracy of liver elastography by acoustic radiation force impulse imaging (ARFI)
Published in European journal of radiology (01-08-2013)“…Abstract Background Acoustic Radiation Force Impulse Imaging (ARFI) is an innovative elastography for staging of liver fibrosis. We evaluated the diagnostic…”
Get full text
Journal Article -
6
Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting
Published in Liver international (01-07-2015)“…Background & Aims Several real world data demonstrated that eligibility for and tolerability of triple therapy against hepatitis C virus (HCV) infection with a…”
Get full text
Journal Article -
7
Anti-HDV IgM as a marker of disease activity in hepatitis delta
Published in PloS one (29-07-2014)“…Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine…”
Get full text
Journal Article -
8
Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls
Published in Liver international (01-01-2018)“…Background & Aims The importance of the intestinal microbiota for the onset and clinical course of many diseases, including liver diseases like non‐alcoholic…”
Get full text
Journal Article -
9
Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection
Published in Liver international (01-11-2009)“…Background and aims: Transient elastography is increasingly being used in patients with chronic liver disease. It has proven particularly useful to identify…”
Get full text
Journal Article -
10
The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus–Specific T Cells
Published in The Journal of infectious diseases (01-01-2017)“…Background. Hepatitis D virus (HDV) infection affects 15–20 million individuals worldwide and causes severely progressive hepatitis. It is unknown to what…”
Get full text
Journal Article -
11
Frequent detection of HCV RNA and HCVcoreAg in stool of patients with chronic hepatitis C
Published in Journal of clinical virology (01-07-2016)“…Highlights • In 69% of patients with chronic HCV infection HCV RNA was detectable in stool. • Patients with HCV RNA-positive stool had lower platelets and were…”
Get full text
Journal Article -
12
Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up
Published in Zeitschrift fur Gastroenterologie (01-09-2017)“…The advent of direct-acting antivirals has revolutionized treatment of chronic hepatitis C with very high cure rates and excellent tolerability compared to…”
Get more information
Journal Article